Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 240-245
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.240
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.240
Subgroup | n | Weight gain(% from baseline) | Mean phlebotomy Volume1(mL) | Liver weight(% of total body weight) | Splenic weight(% of total body weight) |
Sham only | 5 | 15.03 ± 18.70a | 0 ± 0 | 3.97 ± 0.16a | 0.41 ± 0.07a |
Sham and phlebotomy later | 4 | 9.4 ± 7.0 | 0.70 ± 0.13 | 3.62 ± 0.32 | 0.37 ± 0.04 |
Phlebotomy and sham later | 6 | -5.7 ± 17.3 | 0.86 ± 0.18 | 3.47 ± 0.19 | 0.38 ± 0.03 |
BDL only | 9 | -4.99 ± 3.90 | 0 ± 0 | 6.89 ± 1.29 | 0.66 ± 0.10 |
BDL and phlebotomy later | 8 | 8.01 ± 3.1a | 0.71 ± 0.16 | 5.97 ± 0.45 | 0.56 ± 0.07 |
Phlebotomy and BDL later | 8 | -3.29 ± 20.1 | 0.80 ± 0.15 | 7.02 ± 1.68 | 0.69 ±0.13 |
- Citation: Peretz G, Link G, Pappo O, Bruck R, Ackerman Z. Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease. World J Gastroenterol 2006; 12(2): 240-245
- URL: https://www.wjgnet.com/1007-9327/full/v12/i2/240.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.240